Biotech investors in Massachusetts, United States
Updated 16 Nov 2026
Venture funds
5 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Mission BioCapital Mission BioCapital invests in early-stage life science companies, with recent investments including Circle Pharma and Cloverleaf Bio. Cambridge, United States |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 20% | 4 |
| 2 | F-Prime F-Prime invests in healthcare and technology, with recent companies including Albert Invent and Nocion Therapeutics. Cambridge, United States |
Health care, Fintech | Seed, Early stage venture, Late stage venture | 25% | 2 |
| 3 | MassVentures MassVentures supports Massachusetts-based startups, with recent backings including Emvolon and EnVision Endoscopy. Boston, United States |
Health care, Hardware | Seed, Early stage venture, Late stage venture | 26% | 2 |
| 4 | Morningside Morningside invests in companies with novel science and technology, recently backing Pelicargo and Cognito Therapeutics. Newton, United States |
Health care, Biotech | 46% | 2 | |
| 5 | The Engine The Engine supports new companies working on scientific and technological innovation, with recent companies including Hyperlight and Emvolon. Cambridge, United States |
Hardware, Health care | Seed, Early stage venture | 36% | 2 |
Table 1. Biotech investors in Massachusetts, United States: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| RA Capital Management | Startup incubator | Boston, United States | •••@racap.com | 617.77••• |
| MassChallenge | Startup accelerator | Boston, United States | •••@masschallenge.org | |
| F-Prime | Venture capital firm | Cambridge, United States | •••@fprimecapital.com | |
| Polaris Partners | Private equity firm | Boston, United States | •••@polarispartners.com | +1 855••• |
| Omega Funds | Secondary purchaser | Boston, United States | •••@omegafunds.net | |
| MPM Capital | Private equity firm | Boston, United States | •••@mpmcapital.com | +1 617••• |
| Mission BioCapital | Venture capital firm | Cambridge, United States | •••@missionbiocapital.com | +1 617••• |
| Atlas Venture | Venture capital firm | Cambridge, United States | •••@atlasventure.com | 857 20••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
| Firm | Person | Title | Verified email | |
|---|---|---|---|---|
| RA Capital Management | P••• K••• | Managing Partner | p•••@racap.com | In the CSV |
| F-Prime | S••• J••• | General Partner and Co-Founder, Investing in AI Native Software | s•••@fprimecapital.com | In the CSV |
| Polaris Partners | J••• F••• | Founding Partner | j•••@polarispartners.com | In the CSV |
| MPM Capital | C••• B••• M••• | Co Managing Partner | c•••@mpmcapital.com | In the CSV |
| Mission BioCapital | S••• T••• | Managing General Partner | s•••@missionbiocapital.com | In the CSV |
5 verified partner contact rows from organizations on this list, names and emails masked.
- 39 of the 58 biotech investors in Massachusetts, United States have a published email address, 33 a phone number and 57 a website.
- RA Capital Management has the most recorded investments, 544, 183 of them as lead investor.
- 39 of them are investors in at least one company that closed its most recent round in the last 12 months.
- MassChallenge is an investor in 26 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Light Frame's $5.1M seed round on 10 November 2026.
- Software is the most common sector across their 1,120 portfolio companies (68%).
- Early stage venture is the most common investment stage, recorded for 53 of them (91%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors in Massachusetts, United States
30 of 58, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RA Capital Management | Startup incubator, Private equity firm | Boston, United States | Health care, Biotech | Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics | 9 | 544 | 183 | 243 | •••@racap.com | 617.77••• | In the CSV |
| 2 | MassChallenge | Startup accelerator | Boston, United States | Artificial intelligence, Health care | HELIOS, DrizzleX, ScribeUp | 26 | 3,225 | 1,037 | 267 | •••@masschallenge.org | In the CSV | |
| 3 | F-Prime | Venture capital firm | Cambridge, United States | Health care, Fintech | T-Therapeutics, Albert Invent, Immuneel Therapeutics | 4 | 540 | 133 | 113 | •••@fprimecapital.com | In the CSV | |
| 4 | Polaris Partners | Private equity firm, Venture capital firm | Boston, United States | Health care, Artificial intelligence | Faro AI, Triveni Bio, Whisker Labs | 3 | 754 | 215 | 207 | •••@polarispartners.com | +1 855••• | In the CSV |
| 5 | Fidelity | Investment bank | Boston, United States | Health care, Hardware | Zipline International, Tenstorrent, SiMa.ai | 7 | 586 | 178 | 285 | +1-866••• | In the CSV | |
| 6 | Cormorant Asset Management | Hedge fund | Boston, United States | Health care, Biotech | Triveni Bio, Third Arc Bio, BlossomHill Therapeutics | 4 | 276 | 58 | 141 | In the CSV | ||
| 7 | Omega Funds | Secondary purchaser, Venture capital firm | Boston, United States | Biotech, Health care | FoRx Therapeutics | 1 | 161 | 37 | 75 | •••@omegafunds.net | In the CSV | |
| 8 | MPM Capital | Private equity firm, Venture capital firm | Boston, United States | Biotech, Health care | Reunion Neuroscience, Umoja Biopharma, āshibio | 301 | 97 | 105 | •••@mpmcapital.com | +1 617••• | In the CSV | |
| 9 | Morningside | Private equity firm, Venture capital firm | Newton, United States | Health care, Biotech | Pelicargo, Zhide New Energy, Cognito Therapeutics | 4 | 138 | 64 | 23 | In the CSV | ||
| 10 | Johnson & Johnson Innovation | Corporate venture arm | Cambridge, United States | Health care, Biotech | ONL Therapeutics, Flindr Therapeutics, Asgard Therapeutics | 118 | 39 | 26 | In the CSV | |||
| 11 | Mission BioCapital | Venture capital firm | Cambridge, United States | Biotech, Health care | Circle Pharma, Cloverleaf Bio, Integrated Biosciences | 4 | 85 | 17 | 19 | •••@missionbiocapital.com | +1 617••• | In the CSV |
| 12 | Atlas Venture | Venture capital firm | Cambridge, United States | Health care, Biotech | Diagonal Therapeutics | 1 | 638 | 179 | 199 | •••@atlasventure.com | 857 20••• | In the CSV |
| 13 | Wellington Management | Private equity firm, Venture capital firm | Boston, United States | Fintech, Health care | Tabby, Current, Element Biosciences | 4 | 335 | 111 | 160 | •••@wellington.com | 617-95••• | In the CSV |
| 14 | SV Health Investors | Private equity firm, Venture capital firm | Boston, United States | Health care, Biotech | Alchemab Therapeutics | 1 | 325 | 76 | 95 | •••@svlsa.com | +1 617••• | In the CSV |
| 15 | Bain Capital Life Sciences | Private equity firm, Venture capital firm | Boston, United States | Biotech, Health care | CereVasc | 1 | 117 | 41 | 60 | •••@baincapital.com | ||
| 16 | Bantam Group | Angel group, Venture capital firm | Westwood, United States | Artificial intelligence, Hardware | Drive lah, Aikium Inc. | 2 | 166 | 0 | 46 | •••@bantamgroup.com | 781-32••• | |
| 17 | Third Rock Ventures | Venture capital firm | Boston, United States | Biotech, Health care | Terremoto Biosciences | 1 | 154 | 69 | 44 | •••@thirdrockventures.com | (415) ••• | In the CSV |
| 18 | Half Court Ventures | Venture capital firm | Boston, United States | Artificial intelligence, Hardware | Light Frame, Flow Labs, Beacon Biosignals | 4 | 89 | 1 | 17 | In the CSV | ||
| 19 | Taihill Venture | Venture capital firm | Boston, United States | Biotech, Artificial intelligence | Kano Therapeutics, Bot Auto, LeyLine | 65 | 2 | 4 | •••@taihill.vc | In the CSV | ||
| 20 | MassVentures | Venture capital firm | Boston, United States | Health care, Hardware | Emvolon, ZwitterCo, Kytopen | 6 | 476 | 122 | 83 | •••@mass-ventures.com | +1 617••• | In the CSV |
| 21 | Flagship Pioneering | Venture capital firm | Cambridge, United States | Biotech, Health care | Inari, Prologue Medicines, Quotient Therapeutics | 288 | 104 | 72 | 617-86••• | In the CSV | ||
| 22 | Pillar VC | Venture capital firm | Boston, United States | Artificial intelligence, Health care | Addis Energy, OpenHands | 2 | 149 | 26 | 18 | •••@pillar.vc | 857-40••• | In the CSV |
| 23 | PharmStars | Startup accelerator | Boston, United States | Health care, Artificial intelligence | Triomics, Medra AI | 2 | 68 | 62 | 4 | In the CSV | ||
| 24 | Vida Ventures | Venture capital firm | Boston, United States | Biotech, Health care | InduPro | 1 | 67 | 23 | 25 | •••@vidaventures.com | 857-25••• | In the CSV |
| 25 | Innospark Ventures | Venture capital firm | Boston, United States | Artificial intelligence, Biotech | VODA.ai, Persist AI, VideaHealth | 56 | 18 | 5 | In the CSV | |||
| 26 | E14 Fund | Micro VC fund | Cambridge, United States | Artificial intelligence, Hardware | Ramona | 1 | 112 | 12 | 11 | •••@e14fund.com | +1 617••• | In the CSV |
| 27 | The Engine | Venture capital firm | Cambridge, United States | Hardware, Health care | Emvolon, Hyperlight, Kytopen | 4 | 81 | 29 | 3 | •••@engine.xyz | In the CSV | |
| 28 | Broadview Ventures | Venture capital firm | Boston, United States | Health care, Biotech | CroíValve | 1 | 75 | 19 | 12 | •••@broadviewventures.org | 617-34••• | In the CSV |
| 29 | Longwood Fund | Venture capital firm | Boston, United States | Health care, Biotech | Channel Medsystems | 1 | 74 | 11 | 19 | •••@longwoodfund.com | (617)3••• | In the CSV |
| 30 | BDC Capital Corporation | Venture capital firm, Venture debt fund | Wakefield, United States | Hardware, Biotech | Brickeye | 1 | 64 | 15 | 29 | •••@bdcnewengland.com | 207-77••• | In the CSV |
Table 2. Biotech investors in Massachusetts, United States: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 58.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | MassChallenge | Boston, United States | 26 | 325 | HELIOS, DrizzleX, ScribeUp |
| 2 | RA Capital Management | Boston, United States | 9 | 47 | Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics |
| 3 | Fidelity | Boston, United States | 7 | 40 | Zipline International, Tenstorrent, SiMa.ai |
| 4 | MassVentures | Boston, United States | 6 | 35 | Emvolon, ZwitterCo, Kytopen |
| 5 | Half Court Ventures | Boston, United States | 4 | 32 | Light Frame, Flow Labs, Beacon Biosignals |
| 6 | F-Prime | Cambridge, United States | 4 | 75 | T-Therapeutics, Albert Invent, Immuneel Therapeutics |
| 7 | The Engine | Cambridge, United States | 4 | 9 | Emvolon, Hyperlight, Kytopen |
| 8 | Mission BioCapital | Cambridge, United States | 4 | 8 | Circle Pharma, Cloverleaf Bio, Integrated Biosciences |
| 9 | Wellington Management | Boston, United States | 4 | 39 | Tabby, Current, Element Biosciences |
| 10 | Morningside | Newton, United States | 4 | 26 | Pelicargo, Zhide New Energy, Cognito Therapeutics |
| 11 | Cormorant Asset Management | Boston, United States | 4 | 13 | Triveni Bio, Third Arc Bio, BlossomHill Therapeutics |
| 12 | Polaris Partners | Boston, United States | 3 | 73 | Faro AI, Triveni Bio, Whisker Labs |
| 13 | Glasswing Ventures | Boston, United States | 3 | 24 | Enlaye, Lambent, Allure Security Technology |
| 14 | Mass General Brigham Ventures | Cambridge, United States | 2 | 4 | Claris Biotherapeutics, InStride Health |
| 15 | PharmStars | Boston, United States | 2 | 12 | Triomics, Medra AI |
Table 3. Biotech investors in Massachusetts, United States: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Light Frame | Light Frame builds core banking and portfolio management technology for wealth managers. | Fintech | Providence, United States | Seed | $5.1M | 2026-11-10 | $6.8M | Half Court Ventures | 1 to 10 | 2024 |
| Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston, United States | Series C | $100.0M | 2026-11-09 | $244.1M | RA Capital Management | 11 to 50 | 2019 |
| Zipline International Unicorn | Zipline designs, manufactures, and operates drones that deliver medical products. | Hardware | South San Francisco, United States | Series I | $1.5B | 2026-11-05 | $3.6B | Fidelity | 1,001 to 5,000 | 2011 |
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | F-Prime | 51 to 100 | 2022 |
| HELIOS | HELIOS provides an AI-powered hockey platform that uses wearable sensors and video to measure player development. | Artificial intelligence | Portsmouth, United States | Seed | $1.1M | 2026-11-03 | $3.9M | MassChallenge | 11 to 50 | 2018 |
| Emvolon | Emvolon converts wasted resources into low-cost green fuels. | Energy | Woburn, United States | Series A | $22.0M | 2026-10-27 | $24.5M | MassVentures, The Engine | 11 to 50 | 2021 |
| DrizzleX | DrizzleX addresses water waste in apartment buildings. | Software | Santa Fe Springs, United States | Series A | $6.8M | 2026-10-20 | $12.3M | MassChallenge | 11 to 50 | 2019 |
| Tenstorrent Unicorn | Tenstorrent develops AI processors and software for machine learning and data-intensive workloads. | Artificial intelligence | Santa Clara, United States | Series E | $1.5B | 2026-10-19 | $2.5B | Fidelity | 501 to 1,000 | 2016 |
| ScribeUp | ScribeUp embeds subscription management into banking products for fintechs, banks, and credit unions. | Commerce | Los Angeles, United States | Series A | $10.0M | 2026-10-19 | $16.0M | MassChallenge | 11 to 50 | 2021 |
| MuukTest | MuukTest provides an AI-powered software testing platform that helps developers test their software faster. | Artificial intelligence | Raleigh, United States | Seed | $499K | 2026-10-14 | $7.0M | MassChallenge | 11 to 50 | 2019 |
Table 4. Biotech investors in Massachusetts, United States: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 763 | 68% |
| Health care | 368 | 33% |
| Artificial intelligence | 272 | 24% |
| Biotech | 256 | 23% |
| Hardware | 192 | 17% |
| Fintech | 131 | 12% |
| Commerce | 95 | 8% |
| Cybersecurity | 54 | 5% |
| Education | 50 | 4% |
| Energy | 31 | 3% |
Table 5. Biotech investors in Massachusetts, United States: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 53 | 91% |
| Seed investors | 42 | 72% |
| Late stage investors | 31 | 53% |
| Venture investors | 29 | 50% |
| Private equity investors | 17 | 29% |
| Post IPO investors | 15 | 26% |
| Debt investors | 9 | 16% |
| Grant makers | 4 | 7% |
Table 6. Biotech investors in Massachusetts, United States by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Biotech investors in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 7 | 12% |
| 2010s | 20 | 36% |
| 2000s | 13 | 23% |
| 1990s | 5 | 9% |
| 1980s | 5 | 9% |
| 1970s | 2 | 4% |
Table 8. Biotech investors in Massachusetts, United States by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies and its headquarters is in Massachusetts, United States. On 16 November 2026 that is 58 investors.
- 39 rows carry an email address and 33 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 58 rows: 1 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors in Massachusetts, United States are on the list?
- 58, in the file dated 16 November 2026. 39 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 39 of the 58 carry an email address in the download and 33 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 58 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 58 rows, 39 firm email addresses and 33 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 19 of the 39 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.